NUTR METAB CARDIOVAS
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 营养学 Nutrition & Dietetics | SCIE | Q2 | 39/114 |
65.8%
|
| 心脏与心血管系统 Cardiac & Cardiovascular Systems | SCIE | Q2 | 66/237 |
72.2%
|
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q2 | 73/198 |
63.1%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 营养学 Nutrition & Dietetics | SCIE | Q2 | 26/95 JCI 0.89 |
73.7%
|
| 心脏与心血管系统 Cardiac & Cardiovascular Systems | SCIE | Q2 | 53/199 JCI 0.89 |
73.9%
|
| 内分泌学与代谢 Endocrinology & Metabolism | SCIE | Q2 | 53/161 JCI 0.89 |
67.7%
|
Nutrition, Metabolism and Cardiovascular Diseases (NMCD) is a peer-reviewed international journal dedicated to the intricate interplay between nutritional factors, metabolic processes, and cardiovascular health. Published by Elsevier on behalf of the Italian Society of Diabetology and the Italian Society for the Study of Atherosclerosis, the journal serves as a vital resource for clinicians, researchers, and public health professionals. Its scope encompasses original research on the epidemiology, pathophysiology, prevention, and treatment of cardiovascular diseases, with a strong emphasis on the roles of diet, obesity, diabetes, dyslipidemia, and metabolic syndrome. The journal publishes a range of article types, including original research articles, comprehensive reviews, meta-analyses, short communications, and editorials. NMCD is particularly noted for its rigorous peer-review process and its focus on translational research that bridges basic science and clinical application. While not an open access journal by default, NMCD offers an open access option for authors. As of 2026, the journal holds an Impact Factor of 3.900, placing it in the JCR Quartile 2 (Q2) within the categories of Nutrition & Dietetics, Endocrinology & Metabolism, and Cardiac & Cardiovascular Systems. This standing reflects its solid reputation and consistent contribution to the field, making it a respected venue for high-quality research that informs clinical guidelines and public health policy aimed at reducing the global burden of cardiometabolic diseases.